Company / Current Assets
Tandem Diabetes Care Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$618.1M
FY2025
5-year range
$618.1M / $850.0M
FY2021-FY2025
Trend
-14.7%
vs FY2024
Sector context
#97 of 160
Health Care
What the data says
At $618M, Tandem Diabetes Care's current assets ranks #97 of 160 in the Health Care sector. Current Assets has declined for 3 consecutive years, from $850M in FY2022 to $618M in FY2025.
Based on SEC 10-K filings.
$618M in FY2025 with a 5-year CAGR of -0.6%.
Declined from $748M to $618M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -10.1%
- 5-Year CAGR
- -0.6%
- 10-Year CAGR
- -
Sector benchmark
#97 of 160 in Health CareTop 61% of 160This company $618.1M Sector average $5.2B
▼
-88.2% below sector average
Key checks
Key Insights
- Tandem Diabetes Care's current assets has declined for 3 consecutive years.
- 5-year CAGR of -0.6%, indicating a declining trend.
- In FY2025, current assets decreased 14.7% year-over-year.
- Ranks #97 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $618.1M | -14.7% |
| FY2024 | $724.5M | -3.1% |
| FY2023 | $748.0M | -12.0% |
| FY2022 | $850.0M | +4.7% |
| FY2021 | $811.5M | +27.4% |
| FY2020 | $637.2M | +130.8% |
| FY2019 | $276.1M | +47.0% |
| FY2018 | $187.9M | +192.9% |
| FY2017 | $64.2M | -30.3% |
| FY2016 | $92.1M | -13.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026